Showing results (2731-2740 of 4,684) with videos related to
Sort By:
Pageof 469
Chemmedchem|June 19, 2024
Inhibition Clathrin Mediated Endocytosis: Pitstop 1 and Pitstop 2 ChimerasKate Prichard, Ngoc Chau, Jing Xue, et al.Chemmedchem|August 12, 2006
Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activityKornelia Hampel, Ina Kaufhold, Martin Zacharias, et al.Chemmedchem|August 12, 2006
Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinedionesStefanie Weyler, Friederike Fülle, Martina Diekmann, et al.Chemmedchem|August 8, 2006
Design, synthesis, biological evaluation, and molecular modeling studies of TIBO-like cyclic sulfones as non-nucleoside HIV-1 reverse transcriptase inhibitorsRoberto Di Santo, Roberta Costi, Marino Artico, et al.Chemmedchem|August 8, 2006
In vivo antitumor activity of clitocine, an exocyclic amino nucleoside isolated from Lepista inversaHélène Fortin, Sophie Tomasi, Jean-Guy Delcros, et al.Chemmedchem|August 8, 2006
Bisubstrate inhibitors of catechol O-methyltransferase (COMT): the crucial role of the ribose structural unit for inhibitor binding affinityRalph Paulini, Christian Trindler, Christian Lerner, et al.Chemmedchem|August 8, 2006
Comparative analysis of the surface interaction properties of the binding sites of CDK2, CDK4, and ERK2Matthew D Kelly, Ricardo L ManceraChemmedchem|August 8, 2006
Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonistsLian Qian, Yong Xu, Ted Simper, et al.Chemmedchem|August 8, 2006
The potential of P1 site alterations in peptidomimetic protease inhibitors as suggested by virtual screening and explored by the use of C-C-coupling reagentsSteffen Weik, Torsten Luksch, Andreas Evers, et al.Pageof 469